Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
10/13/1999 | EP0948596A1 Poultry eggshell strengthening composition |
10/13/1999 | EP0948595A1 MUTANT $i(OB) RECEPTORS AND NUCLEOTIDES ENCODING THEM |
10/13/1999 | EP0948594A1 Method and device for microinjection of macromolecules into non-adherent cells |
10/13/1999 | EP0948543A1 Hvem polypeptides and uses thereof |
10/13/1999 | EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
10/13/1999 | EP0948538A1 Analysis and separation of platelet-derived growth factor proteins |
10/13/1999 | EP0948537A2 Protein binding fragments of gravin |
10/13/1999 | EP0948535A1 Novel lanthionine antibiotic compositions and methods |
10/13/1999 | EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain |
10/13/1999 | EP0948532A1 Mouse galanin receptor galr2 and nucleotides encoding same |
10/13/1999 | EP0948531A1 Secreted human proteins |
10/13/1999 | EP0948529A1 Human galanin receptor galr2 and nucleotides encoding same |
10/13/1999 | EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN |
10/13/1999 | EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
10/13/1999 | EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
10/13/1999 | EP0948516A1 Method for determining expression of aberrant forms of apc protein |
10/13/1999 | EP0948515A1 Human b-cell translocation genes-2 and 3 |
10/13/1999 | EP0948508A1 Novel coding sequences from herpes simplex virus type-2 |
10/13/1999 | EP0948323A1 Protease-activated receptor 3 and uses thereof |
10/13/1999 | EP0652955B1 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
10/13/1999 | EP0567575B1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof |
10/13/1999 | EP0564592B1 Liver enriched transcription factor |
10/13/1999 | CN1231701A Method and apparatus for detecting bacteria |
10/13/1999 | CN1231697A In vivo protein synthesis method |
10/13/1999 | CN1231696A Homocysteine desulphurase from the protozoan trichomonas vaginalis |
10/13/1999 | CN1231695A HBV polyase, RNase H originated from HBV polyase, its preparation process and application in sieving antivirotic agent |
10/13/1999 | CN1231618A Biodegradation of metal cyanides |
10/13/1999 | CN1231340A Anti-tumor antibiotic and microbiological formentation production method thereof |
10/13/1999 | CN1231336A Bag-cultivating black edible fungus and cultivating technology thereof |
10/13/1999 | CN1045539C CDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophie cellular growth |
10/12/1999 | US5965797 Bacterial genes |
10/12/1999 | US5965791 Vector for introducing a gene into a plant, and methods for producing transgenic plants and multitudinously introducing genes into a plant using the vector |
10/12/1999 | US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides |
10/12/1999 | US5965704 Class two cytokine receptor-11 |
10/12/1999 | US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes |
10/12/1999 | US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines |
10/12/1999 | US5965431 Increasing bioavailability of compounds and mixtures by setting temperature of aqueous medium to 45 degrees celsius or higher and using culture of thermophilic bacteria; solvent-free for pollution control |
10/12/1999 | US5965430 Bioactive substance having antitumor activity, producing strain, and production thereof |
10/12/1999 | US5965429 Streptomyces aureofaciens cell with a recombinant ctc 11 gene whose expression is enhanced compared to wild-type; for industrial biosynthesis of antibiotics |
10/12/1999 | US5965427 Human RAD50 gene and methods of use thereof |
10/12/1999 | US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents |
10/12/1999 | US5965422 Lysophospholipase produced from aspergillus by recombinant methods |
10/12/1999 | US5965418 A protein which catalyzes the oxidation of halide ions in the presence of hydrogen peroxide; microbiocides |
10/12/1999 | US5965417 Arabidepsi thaliana proteins having Δ-5,7-sterol-Δ-7-reductase activity |
10/12/1999 | US5965416 Arginyl tRNA synthetase from staphyloccus aureus |
10/12/1999 | US5965415 Creating hybrid genes by transforming bacteria cells having a defective mismatch repair system or transitorily deactivated with two homologous dna sequences having mismatches, screening cells which have undergone stable recombination |
10/12/1999 | US5965414 Culturing lactobaciilus with carbon source and inducing organosulfur compound; recovering fungicide which is polar, non-protein, non-lipid, low molecular weight, ph and temperature stable |
10/12/1999 | US5965412 For phosphorolysis of kojibiose in presence of phosphoric acid and/or salt forming d-glucose and beta-d-glucose-1-phosphoric acid and/or salt; for transfer of glucosyl group to other saccharides producing oligosaccharides |
10/12/1999 | US5965411 Maltose-trehalose converting enzyme, and preparation and uses thereof |
10/12/1999 | US5965406 A genetically engineered molecule having a cell-binding domain, a translocation domain covalently bond to a toxin and an enzymatically active polypeptide; gene therapy, treatment of acquired immune deficieny syndrome |
10/12/1999 | US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
10/12/1999 | US5965400 DNA encoding a truncated pneumogoccal surface protein (PspA) |
10/12/1999 | US5965396 Human lymph node derived GTPase |
10/12/1999 | US5965392 A nucleic acid molecule; treating obesity or anorexia |
10/12/1999 | US5965391 A structural gene positioned in front of a malate synthase gene which enables controlled expression of desired proteins in corynebacterium by inducing agents added to the medium; genetic engineering |
10/12/1999 | US5965390 Protein L and hybrid proteins thereof |
10/12/1999 | US5965389 Yeast which is transformed with dna construct of regulatory sequences and dna sequence coding glutamate decarboxylase isoform; for high level gene expression and industrial production of enzyme for screening and monitoring of diabetes |
10/12/1999 | US5965386 Yeast strains and modified albumins |
10/12/1999 | US5965384 Culturing aspergillus oryzae transformed with expression vector of regulatory sequences and dna sequences coding for humicola lanuginosa lipase, recovering lipase with different glycosylation and heat and/or proteolytic resistance |
10/12/1999 | US5965383 Fibrin binding domain polypeptides and uses and methods of producing same |
10/12/1999 | US5965381 A mutant strain deficient in producing functional effector proteins; used for heterologous protein transfer into antigen presenting cells; treating infections by pathogens; inducing cellular immune response |
10/12/1999 | US5965368 Determining protein-protein interactions by counterselection of two test proteins expressed in two separate nucleic acid libraries and measuring level of expression of reporter gene operably linked to a dna-binding-protein recognition sites |
10/12/1999 | US5965367 Purified bradykinin B1 receptor |
10/12/1999 | US5965360 Diagnosis of metastatic cancer by the mts-1 gene |
10/12/1999 | US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer |
10/12/1999 | US5965128 Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli |
10/12/1999 | US5964100 For use in cryopreservation |
10/12/1999 | CA2129618C Lactobacillus bulgaricus having decreased acid production and/or improved aroma and flavor production, and food composition comprising said lactobacillus bulgaricus |
10/12/1999 | CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses |
10/07/1999 | WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
10/07/1999 | WO1999050434A1 Strain of the microorganism penicillium oxalicum var. armeniaca and its application |
10/07/1999 | WO1999050432A1 Inducible alphaviral gene expression system |
10/07/1999 | WO1999050428A2 Pathogen-inducible promoter |
10/07/1999 | WO1999050426A1 Vectors for gene mutagenesis and gene discovery |
10/07/1999 | WO1999050423A2 Isochorismate synthase and its use for the induction of resistance in plants |
10/07/1999 | WO1999050422A2 Method for reduction of fusel oils in alcoholic beverages and food products |
10/07/1999 | WO1999050420A1 Method for increasing the phenoxy propionic acid hydroxylation rate |
10/07/1999 | WO1999050416A1 Tnf-related death ligand |
10/07/1999 | WO1999050400A1 Amp deaminase |
10/07/1999 | WO1999050396A1 Nek1-related protein kinase |
10/07/1999 | WO1999050389A1 Microbial strains and processes for the manufacture of biomaterials |
10/07/1999 | WO1999050387A1 Vaccination modalities |
10/07/1999 | WO1999050302A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
10/07/1999 | WO1999050294A1 Novel hemolytic active proteins and genes encoding the same |
10/07/1999 | WO1999050293A1 Chimeric insecticidal protein and gene coding therefore |
10/07/1999 | WO1999050288A2 Mammalian blood loss-induced gene, kd312 |
10/07/1999 | WO1999050278A1 Compositions and methods for the identification of lung tumor cells |
10/07/1999 | WO1999049890A1 A preventive and therapeutic vaccine for helicobacter pylori-associated diseases |
10/07/1999 | WO1999049877A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
10/07/1999 | WO1999038962A3 Compositions and methods for using a lysing matrix for isolating dna |
10/07/1999 | WO1999031128A3 Human tumor necrosis factor-r2-like proteins |
10/07/1999 | WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs |
10/07/1999 | WO1999023221A3 Multivalent antigen-binding proteins |
10/07/1999 | DE19901270A1 Production of beta-1,6-branched beta-1,3-glucan useful as skin anti-aging, depigmenting and healing agent |
10/07/1999 | DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue |
10/07/1999 | DE19814860A1 Bakterielle Transglutaminasen Bacterial transglutaminases |
10/07/1999 | DE19814528A1 Verfahren zur Erhöhung der POPS-Hydroxylierungsrate A method for increasing the POPs hydroxylation |
10/07/1999 | CA2333433A1 Salicylic acid pathway genes and their use for the induction of resistance in plants |
10/07/1999 | CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
10/07/1999 | CA2325564A1 Inducible alphaviral gene expression system |